Autologous whole blood and autologous serum injections are equally effective as placebo injections in reducing disease activity in patients with chronic spontaneous urticaria: a placebo controlled, randomized, single-blind study

2011 ◽  
Vol 23 (6) ◽  
pp. 465-471 ◽  
Author(s):  
Emek Kocatürk ◽  
Selin Aktaş ◽  
Zafer Türkoğlu ◽  
Mukaddes Kavala ◽  
Ilkin Zindanci ◽  
...  
Dermatology ◽  
2006 ◽  
Vol 212 (2) ◽  
pp. 150-159 ◽  
Author(s):  
P. Staubach ◽  
K. Onnen ◽  
A. Vonend ◽  
M. Metz ◽  
F. Siebenhaar ◽  
...  

Author(s):  
Nikolaos Aggelis Kitsioulis ◽  
Efterpi Zafiriou ◽  
Paraskevi Xepapadaki ◽  
Styliani Taka ◽  
Nikolaos G. Papadopoulos ◽  
...  

There is no Abstract.


2021 ◽  
Vol 12 ◽  
Author(s):  
João Marcelino ◽  
Katrine Baumann ◽  
Per Stahl Skov ◽  
Maria Conceição Pereira Santos ◽  
Inga Wyroslak ◽  
...  

Basophil testing is the most effective single approach for diagnosing type-IIb autoimmune chronic spontaneous urticaria (TIIbaiCSU). A positive basophil test has been linked to long disease duration, higher disease activity, a poor response to antihistamines and omalizumab, and a better response to cyclosporine and fenebrutinib. As of now it is unclear what other features are connected to a positive basophil test in chronic spontaneous urticaria (CSU). We aimed to identify features of basophil test-positive CSU patients. We performed a cross-sectional study of 85 CSU patients. Basophil testing was done with the basophil activation test (BAT) and the basophil histamine release assay (BHRA). Data were analysed using SPSS: Student’s t-test, Chi-square test, Odds Ratio, Spearman’s correlation test. Of 85 CSU patients, 44% and 28% tested positive with the BAT and BHRA, respectively. These patients showed higher disease activity and impact, lower levels of disease control and total serum IgE, as well as higher rates of having a positive autologous serum skin test (ASST), angioedema, nocturnal symptoms, symptoms for >5 days/week, and thyroid autoantibodies. The ASST, by itself, was not a good predictor of basophil test results, but it predicted a positive basophil test in up to 100% of cases when combined with angioedema, thyroid autoantibodies or low IgE. In conclusion, a positive basophil test is linked to known features of TIIbaiCSU and novel characteristics including nocturnal symptoms. Further studies on basophil test-positive and -negative CSU patients can help to better understand CSU endotypes and to develop better management approaches.


2017 ◽  
Vol 172 (3) ◽  
pp. 161-166 ◽  
Author(s):  
Nikolaos Aggelis Kitsioulis ◽  
Paraskevi Xepapadaki ◽  
Aggeliki-Victoria Roussaki-Schulze ◽  
Nikolaos Papadopoulos ◽  
Efterpi Zafiriou

Medicine ◽  
2019 ◽  
Vol 98 (25) ◽  
pp. e16127 ◽  
Author(s):  
Leixiao Zhang ◽  
Xianjun Xiao ◽  
Ruting Hui ◽  
Yunzhou Shi ◽  
Yanli Deng ◽  
...  

2015 ◽  
Vol 27 (6) ◽  
pp. 784 ◽  
Author(s):  
Hyang-Suk You ◽  
Hyun-Ho Cho ◽  
Won-Jeong Kim ◽  
Je-Ho Mun ◽  
Margaret Song ◽  
...  

1984 ◽  
Vol 51 (03) ◽  
pp. 347-348 ◽  
Author(s):  
C Cordova ◽  
A Musca ◽  
F Violi ◽  
C Alessandri ◽  
A Ghiselli ◽  
...  

SummaryThe behaviour of plasma malondialdehyde-like material (MDA-LM) was evaluated in 13 healthy subjects by a single-blind study that consisted of placebo (30 days), vitamin E treatment (300 mg/day) (30 days) and placebo (30 days). The study demonstrated that MDA-LM did not change during placebo treatment while it significantly decreased after vitamin E administration.


Sign in / Sign up

Export Citation Format

Share Document